SYRE•benzinga•
Reported Earlier, Spyre Therapeutics Prices $200M Public Offering Of 7.275M Common Shares At $27.50/Share
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 19, 2024 by benzinga